=========================================================================== SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ----------------------------------- DATE OF REPORT: July 11, 2002 DATE OF EARLIEST EVENT REPORTED: July 11, 2002 ICN PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) DELAWARE 1-11397 33-0628076 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of incorporation or Identification Number) organization) 3300 HYLAND AVENUE COSTA MESA, CALIFORNIA 92626 (Address of principal executive offices) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (714) 545-0100 =========================================================================== Item 5. Other Events. ------------ On July 11, 2002, the registrant issued the press release filed as Exhibit 99.1 hereto. Item 7. Financial Statements and Exhibits --------------------------------- Exhibit Description ------- ----------- 99.1 Press release issued July 11, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on behalf of the undersigned hereunto duly authorized. Dated: July 11, 2002 ICN PHARMACEUTICALS, INC. By: /s/ Gregory Keever ----------------------------------------- Name: Gregory Keever Title: Executive Vice President, General Counsel and Corporate Secretary EXHIBIT INDEX Exhibit Description ------- ----------- 99.1 Press release issued July 11, 2002.